Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

652
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
652
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

546
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
546
Glaucoma: Overview01:25

Glaucoma: Overview

727
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
727

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimally invasive corneal neurotization surgery and outcomes in a rural population.

International ophthalmology·2025
Same author

Fungal keratitis after amniotic membrane placement.

American journal of ophthalmology case reports·2024
Same author

Combined <i>Rothia dentocariosa</i> and <i>Streptococcus viridans</i> Corneal Ulcer in an Immunocompromised Patient.

Case reports in ophthalmological medicine·2021
Same author

Corneal Ulcers with NOD2 Mutations Presenting with Mixed Syndromic Phenotype.

Ocular immunology and inflammation·2021
Same author

<i>Chryseobacterium indologenes</i> Keratitis: Successful Treatment of Multidrug-Resistant Strain.

Case reports in ophthalmological medicine·2021
Same author

Congenital Smooth Muscle Hamartoma Obscuring the Cornea.

Case reports in ophthalmological medicine·2021

Related Experiment Video

Updated: Sep 6, 2025

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

2.3K

"Marginal keratitis following COVID 19 vaccination".

Daniel A Farrell1, Sara Deacon2, Thomas Mauger2

  • 1West Virginia University School of Medicine. Morgantown, WV, USA.

Idcases
|June 27, 2022
PubMed
Summary
This summary is machine-generated.

A rare case of marginal keratitis, an eye condition, occurred after a Moderna COVID-19 vaccination. Symptoms resolved with treatment and did not recur after the second vaccine dose.

Area of Science:

  • Ophthalmology
  • Immunology
  • Vaccinology

Background:

  • Marginal keratitis is a localized immune response in the cornea.
  • The COVID-19 vaccine targets the SARS-CoV-2 spike protein, which interacts with ACE2 receptors.
Keywords:
COVID 19 VaccineMarginal KeratitisType III hypersensitivity

More Related Videos

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.4K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.4K

Related Experiment Videos

Last Updated: Sep 6, 2025

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

2.3K
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.4K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.4K